Villa Medical Center Phuket (www.thailandstemcell.com), a subsidiary of Atlantis Bioscience Singapore, has entered a high-impact collaboration with Next Generation Diagnostics (NGD) to implement an expansive quality control (QC) initiative for stem cell therapy products. The partnership represents a significant milestone in Atlantis’s mission to elevate regenerative medicine standards across Southeast Asia and reinforce its clinical-grade commitment to Advanced Therapy Medicinal Products (ATMPs).
As stem cell therapy becomes a cornerstone of modern regenerative healthcare, maintaining consistent quality, genetic safety, and immunological identity is essential. Villa Medical Center Phuket has responded to this imperative by integrating NGD’s internationally certified testing capabilities into its production pipeline to assure maximum therapeutic safety and reproducibility.
Comprehensive Stem Cell Quality Evaluations
NGD’s laboratory will conduct a suite of critical QC analyses on stem cells manufactured and prepared by Atlantis. These include:
– Immunophenotyping – Confirmation of stem cell identity and immunological profile using surface markers such as CD73+, CD90+, and CD105+, and ensuring absence of markers like CD34 or CD45, consistent with mesenchymal stem cell (MSC) definitions.
– Sterility Testing – Screening for microbial contamination, including bacteria and fungi, according to USP and WHO standards, eliminating risk of adverse effects upon transplantation.
– Chromosomal Aberration Testing – Monitoring for structural genomic abnormalities using karyotyping and FISH to ensure genetic integrity through cell expansion phases.
– TP53 Mutation Analysis – A highly specialized test that identifies mutations in the tumor suppressor gene TP53, which can increase oncogenic potential if altered. TP53 screening ensures the stem cells are free from transformation risks and safe for clinical infusion.
Safeguarding the Future of Cell-Based Medicine
Stem cells are only as effective as the quality systems behind them. Without rigorous testing, risks such as immune rejection, oncogenesis, or failure of regenerative action remain elevated. Atlantis’s comprehensive QA/QC strategy helps mitigate these risks and ensures that every patient receives the safest and most effective cell therapy available.
By introducing third-party diagnostic validation from NGD, Atlantis not only enhances safety and compliance but also positions itself for eligibility in international trials, regulatory filings, and cross-border medical partnerships. These steps are critical as global regulatory frameworks continue to tighten oversight on regenerative products.
Aligning with Global Regulatory Standards
Villa Medical Center Phuket follows a fully GMP-aligned manufacturing model, with strict adherence to ISO-certified practices and transparent documentation from source to administration. These protocols include:
– Use of GMP-grade reagents and cryopreservation systems
– Batch-specific documentation for traceability and repeatability
– Serial sterility testing at multiple checkpoints
– Automated and manual quality assessments throughout cell processing
– Long-term stability analysis to confirm sustained cell potency
The company’s quality infrastructure is designed to match regulatory expectations from authorities such as the FDA (U.S.), EMA (Europe), and PMDA (Japan), giving Atlantis global competitiveness and clinical reliability.
Clinical Applications with a Safety-first Approach
The stem cells validated through Atlantis’s QC system are applied in:
– Orthopedic repair and sports injury recovery
– Cosmetic rejuvenation and scar reduction
– Immune modulation for chronic inflammation and autoimmune conditions
– Neuroregeneration for degenerative neurological diseases
– Dental and craniofacial reconstruction
Each of these domains requires cells that meet the highest standards for viability, differentiation capacity, identity, and sterility. Atlantis’s collaboration with NGD ensures those standards are not just met but exceeded.
Thailand’s Role in Biomedical Innovation
As a major player in Thailand’s regenerative medicine ecosystem, Villa Medical Center Phuket is helping shape the country into a regional hub for responsible and science-driven ATMPs. The NGD partnership exemplifies Thailand’s growing capability to meet international benchmarks in cell therapy development, placing it on par with global biomedical innovation centers.
Looking Forward: Quality Is the New Currency
As regenerative medicine continues to expand in scope and acceptance, Villa Medical Center Phuket remains committed to advancing the field with a foundational focus on quality. The integration of advanced diagnostic tools like TP53 screening and chromosomal analysis is part of its broader mission to offer patients around the world not just treatment but trust.
In collaboration with NGD, Atlantis is investing in a future where stem cell therapy is safer, more predictable, and universally accepted by regulators, researchers, and clinicians alike. This level of transparency and commitment positions Atlantis as a frontrunner in ethical, evidence-based cell therapy innovation.
Villa Medical Center Phuket
Villa Sukhothai, Soi Pasak 8, Choeng Thale,
Thalang District, Phuket, Thailand
Email: atlantisphuket@gmail.com
Phone/WhatsApp: +66 99 301 6969